CARM Carisma Therapeutics
- 0.844
- -0.001-0.12%
Carisma Therapeutics News
Carisma Therapeutics | 10-Q: Q3 2024 Earnings Report
Carisma Therapeutics | 8-K: Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Carisma Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Cheng Sohanya Roshan
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cheng Sohanya Roshan
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 10-Q: Q2 2024 Earnings Report
Carisma Therapeutics | 8-K: Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thorell Marella
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Scadden David
Carisma Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Thorell Marella
Carisma Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Scadden David
Carisma Therapeutics | 8-K: Current report
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ZWEIFACH SANFORD S
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Morrison Briggs
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hohneker John
Carisma Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Torok Michael
Carisma Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
No Data